References
- Aderem A, Ulevitch RJ (2000). Toll-like receptors in the induction of the innate immune response. Nature, 406, 782-7. https://doi.org/10.1038/35021228
- Akdis CA, Blaser K (2001). Mechanisms of interleukin-10-mediated immune suppression. Immunology, 103, 131-6. https://doi.org/10.1046/j.1365-2567.2001.01235.x
- Alexander DD, Mink PJ, Adami HO, et al (2007). The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer, 120, 1-39.
-
Beg AA, Baltimore D (1996). An essential role for NF-
$\kappa{B}$ preventing TNF-a-induced cell death. Science, 274, 782-4. https://doi.org/10.1126/science.274.5288.782 - Chang ET, Birmann BM, Kasperzyk JL, et al (2009). Polymorphic variation in NFKB1 and other aspirin-related genes and risk of hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev, 18, 976-86. https://doi.org/10.1158/1055-9965.EPI-08-1130
- Chen G, Goeddel DV (2002). TNF-R1 signaling: a beautiful pathway. Science, 296, 1634-5. https://doi.org/10.1126/science.1071924
- Fernberg P, Chang ET, Duvefelt K, et al (2010). Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma. Cancer Causes Control, 21, 759-69. https://doi.org/10.1007/s10552-010-9504-y
- Forrest MS, Skibola CF, Lightfoot TJ, et al (2006). Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol, 134, 180-3. https://doi.org/10.1111/j.1365-2141.2006.06141.x
- Ghosh S, Hayden MS (2008). New regulators of NF-kappaB in inflammation. Nat Rev Immunol, 8, 837-48. https://doi.org/10.1038/nri2423
- Hayden MS, West AP, Ghosh S (2006). NF-kappaB and the immune response. Oncogene, 25, 6758-80. https://doi.org/10.1038/sj.onc.1209943
- Hellmig S, Fischbach W, Goebeler-Kolve ME, et al (2005). Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosaassociated lymphoid tissue lymphoma. Leuk Lymphoma, 46, 869-72. https://doi.org/10.1080/1042819050086451
- Hollegaard MV, Bidwell JL (2006). Cytokine gene polymorphism in human disease: on-line databases, supplement3. Genes Immun, 7, 269-76. https://doi.org/10.1038/sj.gene.6364301
- Kishimoto T (2006). Interleukin-6:discovery of a pleiotropic cytokine. Arthritis Res Ther, 8, 2.
-
Lu ZM, Zhang Q, Zu YJ, et al (2008). Association between TNF-
$\alpha$ -308 genetic polymorphism and moderate- or high-grade non-Hodgkin's lymphoma. Chinese J Internal Medicine, 47, 500-2. - Nieters A, Beckmann L, Deeg E, et al (2006). Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk. Genes Immun, 7, 615-24. https://doi.org/10.1038/sj.gene.6364337
- Park BS, Song DH, Kim HM, et al (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature, 458, 1191-5. https://doi.org/10.1038/nature07830
- Pfeffer K (2003). Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev, 14, 185-91. https://doi.org/10.1016/S1359-6101(03)00022-4
- Picard C, Casanova JL (2004). Inherited disorders of cytokines. Curr Opin Pediatr, 16, 648-58. https://doi.org/10.1097/01.mop.0000145919.92477.5f
- Purdue MP, Lan Q, Kricker A, et al (2007). Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis, 8, 704-12.
- Purdue MP, Lan Q, Wang SS, et al (2009). A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin Lymphoma. Carcinogenesis, 30, 275-81.
- Rothman N, Skibola CF, Wang SS, et al (2006). Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol, 7, 27-38. https://doi.org/10.1016/S1470-2045(05)70434-4
- Silverman N, Maniatis T (2001). NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev, 15, 2321-42. https://doi.org/10.1101/gad.909001
- Song N, Han S, Lee KM, et al (2012). Genetic variants in interleukin-2 and risk of lymphoma among children in Korea. Asian Pac J Cancer Prev, 13, 621-3. https://doi.org/10.7314/APJCP.2012.13.2.621
- Wang SS, Cerhan JR, Hartge P, et al (2006). Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res, 66, 9771-80. https://doi.org/10.1158/0008-5472.CAN-06-0324
- Zhao HY, Chen YX, Zhong XY, et al (2002). Study on the relationship between tumor necrosis factor genetic polymorphism and pathogenesis of non-Hodgkin's lymphoma. Leukemia&Lymphoma, 11, 275-8.
Cited by
- Distribution of allelic and genotypic frequencies of IL1A, IL4, NFKB1 and PAR1 variants in Native American, African, European and Brazilian populations vol.9, pp.1, 2016, https://doi.org/10.1186/s13104-016-1906-9